… advent of tumor necrosis factor (TNF) antagonists represented a radical change in the
management of inflammatory bowel disease (IBD). Both in short- and long-term, anti-TNF therapy …

… typical Crohn's disease in eight cases, Crohn's-like disease in … For all cases, each TNF-α
blocking agent was discontinued … Cases of inflammatory bowel disease appearing under TNFα …

… of antibodies against anti-TNF-α drugs and the relationship … TNF-α antibodies and
measuring drug serum levels to optimise treatment of patients with inflammatory bowel disease …

… TNF-α Tumor necrosis factor α (TNF-α) belongs to a family of structurally related ligands that
… Almost all members of the TNF familiy exert their effects as transmembrane proteins through …

… Currently, anti-TNF antibodies represent the main group of biologic … TNF-α blockade in our
mathematical model. For modeling the TNF-α blockade, we fix the concentration of TNF-α (I α …

… inflammatory bowel disease (IBD). Many of the in vivo activities of tumor necrosis factor a
(TNF-… of TNF-a secreting cells isolated from mucosal biopsy specimens of children with Crohn’s …

… (anti-TNF) antagonists have been the mainstay in the treatment of inflammatory bowel
diseases (… Summary: This review article aimed to provide an update on recent advances in TNF …

… bowel disease (IBD)have paralleled our understanding of the pathophysiology of ulcerative
colitisand Crohn’s disease. … of ulcerative colitis andCrohn’s disease have been elucidated. …

… to assess the impact of peri-operative use of TNFα antagonists on post-operative complications
such as infection and wound healing in patients with inflammatory bowel disease (IBD). …

… (Crohn’s disease OR inflammatory bowel disease OR ulcerative … (tumor necrosis factor OR
tumor necrosis factor-alpha OR TNF) AND (Crohn’s disease OR inflammatory bowel disease …